REVIEW article
Front. Immunol.
Sec. Cancer Immunity and Immunotherapy
Volume 16 - 2025 | doi: 10.3389/fimmu.2025.1540610
Zebrafish xenografts in breast cancer research
Provisionally accepted
- 1Public Center of Experimental Technology, the school of Basic medical science, Southwest medical university, Luzhou, Sichuan Province, China
- 2School of Stomatology, Southwest Medical University, Luzhou, China
- 3Institute of Cardiovascular Research, Southwest Medical University, Luzhou, Sichuan, China
- 4Department of Pathology, The Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan Province, China
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Breast cancer (BC) tops the list of all malignancies diagnosed in women worldwide, with many patients diagnosed only at the metastatic stage. Current therapeutic paradigms integrating early detection modalities and multimodal treatment strategies have improved outcomes, yet persistent challenges in managing advanced/metastatic cases result in suboptimal 5-year survival rates. Therefore, it is imperative to develop novel therapeutic strategies for BC. Zebrafish breast cancer models have received great attention in this regard, and this review highlights recent advances in BC research involving these zebrafish models. In vivo research using zebrafish models is becoming increasingly valuable for studying BC invasion and metastasis, tumor angiogenesis, and screening for novel therapeutic molecules. These studies have provided insights into the molecular mechanisms of BC, potential drug targets and their efficacy and toxicity, and the application of zebrafish in personalized medicine research. Against this background, this review provides a systematic analysis of the recent advances in zebrafish BC model research regarding brain metastasis, bone metastasis, tumor angiogenesis, and drug screening. The review also critically evaluates the strengths and limitations of the zebrafish model organism, while delineating the future research directions in this field.
Keywords: zebrafish xenograft model, breast cancer, invasion, metastasis, Angiogenesis, drug screening
Received: 11 Dec 2024; Accepted: 23 Jun 2025.
Copyright: © 2025 Rong, Chen, Guo, Sun, Li, Ye, Yang, Nian and Yuan. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Qing Yuan, Public Center of Experimental Technology, the school of Basic medical science, Southwest medical university, Luzhou, Sichuan Province, China
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.